Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials
Files
Publication date
2019-07
Authors
Zoccali, Carmine
Blankestijn, Peter J.
Bruchfeld, Annette
Capasso, Giovambattista
Fliser, Danilo
Fouque, Denis
Goumenos, Dimitrios
Ketteler, Markus
Massy, Ziad
Rychlık, Ivan
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
The exclusion of chronic kidney disease (CKD) patients from clinical trials-particularly cardiovascular trials-remains a long-standing, unsolved problem, which prevents the optimization of clinical care in these patients. The situation recalls the insufficient recruitment of women in cardiovascular trials until the 1980s, a problem that was only resolved following regulatory interventions. Regulatory agencies are in a unique position to promote recruitment of CKD patients in clinical trials. The main stakeholders, namely patients' associations and scientific societies, should make major lobbying efforts to persuade these agencies that the issue is an absolute public health priority.
Keywords
CKD, Cardiovascular, Clinical trial, Diabetes mellitus, Guidelines, clinical trial, guidelines, diabetes mellitus, cardiovascular, Taverne, Nephrology, Transplantation, Journal Article
Citation
Zoccali, C, Blankestijn, P J, Bruchfeld, A, Capasso, G, Fliser, D, Fouque, D, Goumenos, D, Ketteler, M, Massy, Z, Rychlık, I, Soler, M, Stevens, K, Spasovski, G & Wanner, C 2019, 'Children of a lesser god : exclusion of chronic kidney disease patients from clinical trials', Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol. 34, no. 7, pp. 1112-1114. https://doi.org/10.1093/ndt/gfz023